3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase 3
1
Status
Completed
3
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
3
Other hematologic neoplasm
1
Lymphoid
1
Endocrine
1
Conditions
Osteoporosis
6
Breast Neoplasms
6
Bone Diseases, Metabolic
3
Triple Negative Breast Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Carcinoma In Situ
1
Interventions
Zoledronic Acid
3
Risedronic Acid
3
Letrozole
2
Exercise Movement Techniques
1
Denosumab
1
Calcium
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Bone Diseases, Metabolic
×
Risedronic Acid
×
Breast
×
Clear all
NCT00485953
2017-10-13
REBBeCA II
University of Pittsburgh
Phase 4
Completed
109 enrolled
11 charts
NCT00859703
2013-10-31
RISAROS
Hospices Civils de Lyon
Phase 3
Completed
20 enrolled
NCT00082277
2011-01-26
SABRE
AstraZeneca
Phase 4
Completed
237 enrolled